Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Boots Online Doctor has revealed the 'very common' side-effects of Mounjaro you need to know about after thousands of people ...

The UK’s drug regulator is to study possible serious side effects of glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro). Data from ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new study into side effects of GLP-1 medicines ...

Patients have reported being hospitalised with inflammation of the pancreas suspected to be related to medicines such as ...